APPCHECK Pricing Overview

APPCHECK does not offer a permanent free plan, but it does provide a free trial that lets users to test the product before committing to a paid plan. Trial availability and duration may vary, so users should review the seller's official pricing page for the most current details.

According to G2 reviewers, APPCHECK's pricing is best suited for mid-market organizations (51–1,000 employees) across IT services, financial services, healthcare, and consulting that need to replace infrequent manual penetration tests with continuous automated scanning. Small businesses in software development, internet, and medical devices also appear frequently in G2 reviews, citing ISO 27001 compliance and CI/CD integration as primary drivers. Enterprise reviewers in retail, utilities, and government highlight multi-site scan management and vulnerability assignment workflows. APPCHECK's pricing model — custom-quoted with unlimited rescans — particularly suits teams running frequent release cycles or managing multiple web applications, where per-engagement pen test costs would otherwise scale prohibitively.

APPCHECK's pricing structure on G2 shows three tiers — Web App and API security assessment, Network Vulnerability Assessment, and Trust Monitor — each available via free trial rather than a permanent free version. The free trial functions as a time-limited evaluation of APPCHECK's paid licensed capabilities. G2 reviewers consistently describe trialing APPCHECK against competing tools before purchasing, with one mid-market healthcare reviewer running a formal POC against five other DAST tools. APPCHECK's paid plans unlock unlimited scheduled and ad-hoc scans, Jira and CI/CD pipeline integrations, multi-target management, continuous monitoring, and professional reporting — none of which are available on an ongoing basis without a paid license.

G2 reviewers overwhelmingly rate APPCHECK's pricing as strong value, with an average rating of 5.0 across the majority of reviews. The most frequently cited value driver is replacing costly annual manual penetration tests with unlimited automated scanning at comparable or lower cost. Multiple G2 reviewers across small business, mid-market, and enterprise segments explicitly note saving significant budget previously spent on external pen testers. One enterprise reviewer notes APPCHECK 'could be cheaper but it is worth paying more for,' reflecting premium-but-justified sentiment. A small business reviewer in medical devices highlights running bimonthly scans at no additional cost versus prior per-engagement fees. One reviewer flags CVSS scoring alignment as a gap, but this does not materially affect value sentiment.